Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli

Coronary artery disease (CAD) is the leading cause of death worldwide and has a strong link to familial hypercholesterolemia (FH). FH is an autosomal dominant lipoprotein metabolic condition that causes an increase in LDL-c levels and an elevated risk of premature CAD (pCAD). Elevation of proprotein...

Full description

Saved in:

Bibliographic Details
Main Author:	Zulkapli, Rahayu
Format:	Thesis
Language:	English
Published:	2024
Subjects:	QM Human anatomy Biomedical engineering
Online Access:	https://ir.uitm.edu.my/id/eprint/102188/1/102188.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-uitm-ir.102188
record_format	uketd_dc
spelling	my-uitm-ir.1021882024-11-12T06:40:32Z Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli 2024 Zulkapli, Rahayu QM Human anatomy Biomedical engineering Coronary artery disease (CAD) is the leading cause of death worldwide and has a strong link to familial hypercholesterolemia (FH). FH is an autosomal dominant lipoprotein metabolic condition that causes an increase in LDL-c levels and an elevated risk of premature CAD (pCAD). Elevation of proprotein convertase subtilisin/kexin type 9 (PCSK9) level in pCAD patients may contribute to the initiation of atherogenesis by an increase in inflammation. One of the gene mutations present in FH involves a gain-of-function point mutation in PCSK9. Individuals with FH are more likely to have high Lp(a) levels than the general population. Despite extensive research, the underlying mechanism by which Lp(a) mediates atherogenesis and inflammation is still incompletely understood. The release of PCSK9 during inflammation in atherosclerosis suggests that, in addition to the elevation of Lp(a), a potential correlation could exist between Lp(a) and PCSK9. Targeting Lp(a) and PCSK9 might provide an additive benefit beyond LDL-c lowering. The anti-atherogenic properties of PCSK9 inhibitors on atherogenesis biomarkers via PCSK9 reduction have yet to be established. Hence, this study aimed to (1) investigate the enhancement of PCSK9 production by LPS and Lp(a)-stimulation in human coronary artery endothelial cells (HCAEC), (2) determine the pleiotropic effects of PCSK9 inhibitors in LPS and (3) Lp(a)-stimulated HCAEC on atherogenesis biomarkers, and monocyte endothelial cell binding capacity, (4) explore the correlation and association between Lp (a) and PCSK9, and (5) determine the role of Lp(a) and PCSK9 as independent predictors for CAD in pCAD patients. This study was divided into two parts, in vitro and human studies. For the in vitro study, the stimulation effects on PCSK9 production, followed by the determination of pleiotropic effects of PCSK9 inhibitors on atherogenesis biomarkers were determined using ELISA (protein), QuantiGene Plex 96-well (gene), and monocyte binding capacity. For human studies, pCAD (with and without clinically diagnosed FH) and normal controls (NC) were subjected to blood samples to analyse Lp(a) and PCSK9 concentrations. 2024 Thesis https://ir.uitm.edu.my/id/eprint/102188/ https://ir.uitm.edu.my/id/eprint/102188/1/102188.pdf text en public phd doctoral Universiti Teknologi MARA (UiTM) Faculty of Medicine Md Nawawi, Hapizah
institution	Universiti Teknologi MARA
collection	UiTM Institutional Repository
language	English
advisor	Md Nawawi, Hapizah
topic	QM Human anatomy Biomedical engineering
spellingShingle	QM Human anatomy Biomedical engineering Zulkapli, Rahayu Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli
description	Coronary artery disease (CAD) is the leading cause of death worldwide and has a strong link to familial hypercholesterolemia (FH). FH is an autosomal dominant lipoprotein metabolic condition that causes an increase in LDL-c levels and an elevated risk of premature CAD (pCAD). Elevation of proprotein convertase subtilisin/kexin type 9 (PCSK9) level in pCAD patients may contribute to the initiation of atherogenesis by an increase in inflammation. One of the gene mutations present in FH involves a gain-of-function point mutation in PCSK9. Individuals with FH are more likely to have high Lp(a) levels than the general population. Despite extensive research, the underlying mechanism by which Lp(a) mediates atherogenesis and inflammation is still incompletely understood. The release of PCSK9 during inflammation in atherosclerosis suggests that, in addition to the elevation of Lp(a), a potential correlation could exist between Lp(a) and PCSK9. Targeting Lp(a) and PCSK9 might provide an additive benefit beyond LDL-c lowering. The anti-atherogenic properties of PCSK9 inhibitors on atherogenesis biomarkers via PCSK9 reduction have yet to be established. Hence, this study aimed to (1) investigate the enhancement of PCSK9 production by LPS and Lp(a)-stimulation in human coronary artery endothelial cells (HCAEC), (2) determine the pleiotropic effects of PCSK9 inhibitors in LPS and (3) Lp(a)-stimulated HCAEC on atherogenesis biomarkers, and monocyte endothelial cell binding capacity, (4) explore the correlation and association between Lp (a) and PCSK9, and (5) determine the role of Lp(a) and PCSK9 as independent predictors for CAD in pCAD patients. This study was divided into two parts, in vitro and human studies. For the in vitro study, the stimulation effects on PCSK9 production, followed by the determination of pleiotropic effects of PCSK9 inhibitors on atherogenesis biomarkers were determined using ELISA (protein), QuantiGene Plex 96-well (gene), and monocyte binding capacity. For human studies, pCAD (with and without clinically diagnosed FH) and normal controls (NC) were subjected to blood samples to analyse Lp(a) and PCSK9 concentrations.
format	Thesis
qualification_name	Doctor of Philosophy (PhD.)
qualification_level	Doctorate
author	Zulkapli, Rahayu
author_facet	Zulkapli, Rahayu
author_sort	Zulkapli, Rahayu
title	Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli
title_short	Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli
title_full	Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli
title_fullStr	Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli
title_full_unstemmed	Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli
title_sort	effects of pcsk9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between pcsk9 and lipoprotein (a), and as independent predictors for coronary artery disease in premature cad patients / rahayu zulkapli
granting_institution	Universiti Teknologi MARA (UiTM)
granting_department	Faculty of Medicine
publishDate	2024
url	https://ir.uitm.edu.my/id/eprint/102188/1/102188.pdf
_version_	1818588033218248704

Effects of PCSK9 inhibitors on atherogenesis biomarkers in stimulated human coronary artery endothelial cells, correlation between PCSK9 and lipoprotein (A), and as independent predictors for coronary artery disease in premature CAD patients / Rahayu Zulkapli

Similar Items